Stan Eapen

Stan Eapen serves as the Managing Director at 21GRAMS since 2020, bringing extensive experience in the pharmaceutical and healthcare sectors. Prior to this role, Stan was a Cofounder and Managing Partner at Arcus Medica from 2013 to 2020, where the firm was later acquired by Real Chemistry/W2O Group. Earlier career highlights include positions as Senior Product Manager and Senior Medical Science Liaison at Genentech from 2006 to 2012, Area Business Manager at Biogen Idec from 2004 to 2006, and Oncology Sales Representative at Schering Plough from 2000 to 2004. Stan holds a Doctor of Pharmacy (Pharm.D.) from the University of Houston and an MBA in Management and Finance from the A.B. Freeman School of Business at Tulane University.